5/8/2012 REGN Regeneron Pharmaceuticals Arcalyst (sBLA) FDA panel to review Arcalyst for addnl indication in preventing gout flares in patients initiating uric acid-lowering therapy
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.